Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Benjamin

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Respiratory Medicine|September 6, 2023
Endobronchial lung volume reduction with valves reduces exacerbations in severe emphysema patientsJudith Maria Brock, Felix Böhmker, Paul Ulrich Schuster, et al.
Respiration; International Review of Thoracic Diseases|July 30, 2020
Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort StudyChristian Nagel, Mohammed Nasereddin, Nicola Benjamin, et al.
Respiration; International Review of Thoracic Diseases|August 9, 2017
Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial HypertensionChristian Nagel, Ralf Ewert, Benjamin Egenlauf, et al.
Respiratory Research|January 18, 2023
Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri<sup>®</sup>): a prospective, 6-months, open label, observational, non-interventional studyJulia Degering, Benjamin Egenlauf, Satenik Harutyunova, et al.
Respiration; International Review of Thoracic Diseases|September 19, 2018
Survival after Endoscopic Valve Therapy in Patients with Severe EmphysemaDaniela Gompelmann, Nicola Benjamin, Elena Bischoff, et al.
Trials|April 19, 2023
Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trialEglė Palevičiūtė, Jelena Čelutkienė, Toma Šimbelytė, et al.
Respiratory Research|May 26, 2020
Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-upPanagiota Xanthouli, Maria Koegler, Alberto M Marra, et al.
Respiration; International Review of Thoracic Diseases|May 12, 2017
Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination TreatmentEkkehard Grünig, Johanna Ohnesorge, Nicola Benjamin, et al.
The European Respiratory Journal|March 23, 2018
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosisJ Gerry Coghlan, Matthias Wolf, Oliver Distler, et al.
Respiration; International Review of Thoracic Diseases|May 27, 2021
The Experience, Prerequisites, and the Barriers in Organizing a Specialized Rehabilitation Program for Patients with Pulmonary HypertensionEglė Palevičiūtė, Lina Gumbienė, Elena Jurevičienė, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Respiratory Medicine|September 6, 2023
Endobronchial lung volume reduction with valves reduces exacerbations in severe emphysema patientsJudith Maria Brock, Felix Böhmker, Paul Ulrich Schuster, et al.
Respiration; International Review of Thoracic Diseases|July 30, 2020
Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort StudyChristian Nagel, Mohammed Nasereddin, Nicola Benjamin, et al.
Respiration; International Review of Thoracic Diseases|August 9, 2017
Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial HypertensionChristian Nagel, Ralf Ewert, Benjamin Egenlauf, et al.
Respiratory Research|January 18, 2023
Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri<sup>®</sup>): a prospective, 6-months, open label, observational, non-interventional studyJulia Degering, Benjamin Egenlauf, Satenik Harutyunova, et al.
Respiration; International Review of Thoracic Diseases|September 19, 2018
Survival after Endoscopic Valve Therapy in Patients with Severe EmphysemaDaniela Gompelmann, Nicola Benjamin, Elena Bischoff, et al.
Trials|April 19, 2023
Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trialEglė Palevičiūtė, Jelena Čelutkienė, Toma Šimbelytė, et al.
Respiratory Research|May 26, 2020
Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-upPanagiota Xanthouli, Maria Koegler, Alberto M Marra, et al.
Respiration; International Review of Thoracic Diseases|May 12, 2017
Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination TreatmentEkkehard Grünig, Johanna Ohnesorge, Nicola Benjamin, et al.
The European Respiratory Journal|March 23, 2018
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosisJ Gerry Coghlan, Matthias Wolf, Oliver Distler, et al.
Respiration; International Review of Thoracic Diseases|May 27, 2021
The Experience, Prerequisites, and the Barriers in Organizing a Specialized Rehabilitation Program for Patients with Pulmonary HypertensionEglė Palevičiūtė, Lina Gumbienė, Elena Jurevičienė, et al.
Pageof 8